Ligand Pharmaceuticals, Inc. (LGND)

you can hold it life long

big payout...take it for a short spin afterwards!

Ligand has a number of good partnerships with strong pharma companies and they seem to have several good products in the pipeline. Buzz is about that Ligand is a potential target for acquisition but that's just hearsay; nevertheless, I think they could do quite well. Lots of inside ownership. I'll wait until the May 6 conference call and then make a purchasing decision.

As patents for drugs begin to expire this year, many Japanese drug companies are looking to smaller U.S. based corporations to get a foothold on new products to offset their anticipated losses from the expiration of the patents. I foresee LGND being considered for acquisition, and the speculation will likely drive it's price up. They also have several upcoming releases which will spark their sales % upwards pending FDA approvals, and their current price is far below it's future potential.

super nice dividend and management. the company is turning around and making lot of money.

Funding and collaborations spell success in their R&D. This is a good foundation to build on for the future. Hopefully there will be more good news to come from this company

http://valueplays.blogspot.com/2007/06/this-weeks-insider-buys.html

I really screwed up on this one. Bought it quickly and added it to Caps without really doing DD. Got the divi
but lost the war. I did a really amateurish move. Thinking that the stock price would not go down the 2.50 that they were giving out in the divi. As I researched -- seems near term the remaining company might be worth a lot less the the 7 price of today - at least in the near term. Open to anyone that can show me different. I bailed on my stock with a loss and I am getting ready to reverse my opinion here. Waiting for a bouce before I reverse my call to negative.

Accumulate under $3.

Potential buy-out target.

Avoid this like the plague. This is another one of those "Jack Of All Trades" companies that never really gets anywhere. Skip this until they get a better mission statement developed.

just bought in real P F

I like the objective of working on orphan illnesses as a way to support business while working on cancer as a longer shot.

Appears to have no direction and bad ratios.

good protential

stockastic is crossing on the wat up

Nice

Doubled my original investment into LDND today. Believe this is one biotech that will outperform in the coming years.

An interesting biotech model on royalties only. LGND is a lean and successful biotech company. Let the juggernauts make care of pitching the drugs to doctors. Do what LGND is good at, i.e. R&D.

zz